These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results. Di Costanzo A; Trojsi F; Giannatempo GM; Vuolo L; Popolizio T; Catapano D; Bonavita S; d'Angelo VA; Tedeschi G; Scarabino T J Exp Clin Cancer Res; 2006 Sep; 25(3):383-90. PubMed ID: 17167979 [TBL] [Abstract][Full Text] [Related]
3. Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy. Di Costanzo A; Scarabino T; Trojsi F; Giannatempo GM; Popolizio T; Catapano D; Bonavita S; Maggialetti N; Tosetti M; Salvolini U; d'Angelo VA; Tedeschi G Neuroradiology; 2006 Sep; 48(9):622-31. PubMed ID: 16752135 [TBL] [Abstract][Full Text] [Related]
4. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors. Astrakas LG; Zurakowski D; Tzika AA; Zarifi MK; Anthony DC; De Girolami U; Tarbell NJ; Black PM Clin Cancer Res; 2004 Dec; 10(24):8220-8. PubMed ID: 15623597 [TBL] [Abstract][Full Text] [Related]
5. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging. Zeng QS; Li CF; Liu H; Zhen JH; Feng DC Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287 [TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy. Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039 [TBL] [Abstract][Full Text] [Related]
8. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239 [TBL] [Abstract][Full Text] [Related]
9. Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers. Marcus KJ; Astrakas LG; Zurakowski D; Zarifi MK; Mintzopoulos D; Poussaint TY; Anthony DC; De Girolami U; Black PM; Tarbell NJ; Tzika AA Int J Oncol; 2007 Mar; 30(3):651-7. PubMed ID: 17273766 [TBL] [Abstract][Full Text] [Related]
10. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema. Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234 [TBL] [Abstract][Full Text] [Related]
11. Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors. Tzika AA; Astrakas LG; Zarifi MK; Zurakowski D; Poussaint TY; Goumnerova L; Tarbell NJ; Black PM Cancer; 2004 Mar; 100(6):1246-56. PubMed ID: 15022293 [TBL] [Abstract][Full Text] [Related]
13. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors]. Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499 [TBL] [Abstract][Full Text] [Related]
14. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas. Catalaa I; Henry R; Dillon WP; Graves EE; McKnight TR; Lu Y; Vigneron DB; Nelson SJ NMR Biomed; 2006 Jun; 19(4):463-75. PubMed ID: 16763973 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values. Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403 [TBL] [Abstract][Full Text] [Related]
16. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Fayed N; Dávila J; Medrano J; Olmos S Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients. Li X; Lu Y; Pirzkall A; McKnight T; Nelson SJ J Magn Reson Imaging; 2002 Sep; 16(3):229-37. PubMed ID: 12205577 [TBL] [Abstract][Full Text] [Related]
18. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy. Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898 [TBL] [Abstract][Full Text] [Related]
19. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas. Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395 [TBL] [Abstract][Full Text] [Related]
20. Central neurocytoma: proton MR spectroscopy and diffusion weighted MR imaging findings. Kocaoglu M; Ors F; Bulakbasi N; Onguru O; Ulutin C; Secer HI Magn Reson Imaging; 2009 Apr; 27(3):434-40. PubMed ID: 18789624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]